Rulemaking action by the Iowa Board of Pharmacy has been published in the Iowa Administrative Bulletin as follows: 

Adopted 

ARC 6843C has been adopted and amends Chapter 10, “Controlled Substances.” 

  • The rulemaking temporarily places one substance (a hallucinogen) into Schedule I of the Iowa CSA in response to similar scheduling action taken by the DEA.
  • The rulemaking becomes effective March 15, 2023.

ARC 6844C has been adopted and amends Chapter 37, “Iowa Prescription Monitoring Program.”

  • The rulemaking:
    • establishes council membership information for the Prescription Monitoring Program (PMP) Advisory Council and
    • Clarifies that only overdose-reversal opioid antagonists are required to be submitted to the PMP.
  • The rulemaking becomes effective March 15, 2023.

Notice of Intended Action

ARC 6874C has been published as a Notice of Intended Action to amend Chapter 10, “Controlled Substances,” and Chapter 12, “Precursor Substances.”

  • The proposed rule making temporarily adds four substances (three stimulants and one opiate) to Schedule I, excludes one substance from Schedule II, and adds one substance as a precursor substance to the Iowa Controlled Substances Act in response to similar action taken by the DEA.
  • Comments may be submitted until 4:30pm on February 28, 2023.